CACYBP and Alzheimer disease: The cohort analysis further suggests a protective effect against AD, with the incidence of AD decreasing by 12%, 10%, and 13% for each SD increase in the blood levels of CACYBP, PVALB, and TNFAIP8 proteins, respectively.